MENU
+Compare
VCEL
Stock ticker: NASDAQ
AS OF
Jul 23, 02:31 PM (EDT)
Price
$40.15
Change
+$2.17 (+5.71%)
Capitalization
1.91B

VCEL Vericel Corp Forecast, Technical & Fundamental Analysis

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets... Show more

VCEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for VCEL with price predictions
Jul 22, 2025

Momentum Indicator for VCEL turns negative, indicating new downward trend

VCEL saw its Momentum Indicator move below the 0 level on July 02, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 92 similar instances where the indicator turned negative. In of the 92 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for VCEL turned negative on June 16, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at .

VCEL moved below its 50-day moving average on July 07, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for VCEL crossed bearishly below the 50-day moving average on July 08, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VCEL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for VCEL entered a downward trend on July 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where VCEL's RSI Oscillator exited the oversold zone, of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VCEL advanced for three days, in of 296 cases, the price rose further within the following month. The odds of a continued upward trend are .

VCEL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. VCEL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.472) is normal, around the industry mean (18.132). VCEL's P/E Ratio (759.600) is considerably higher than the industry average of (58.972). VCEL's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.463). Dividend Yield (0.000) settles around the average of (0.042) among similar stocks. P/S Ratio (8.299) is also within normal values, averaging (274.444).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
VCEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

VCEL is expected to report earnings to fall 86.39% to -3 cents per share on July 31

Vericel Corp VCEL Stock Earnings Reports
Q2'25
Est.
$-0.03
Q1'25
Missed
by $0.10
Q4'24
Beat
by $0.07
Q3'24
Beat
by $0.03
Q2'24
Missed
by $0.01
The last earnings report on May 08 showed earnings per share of -23 cents, missing the estimate of -13 cents. With 113.48K shares outstanding, the current market capitalization sits at 1.91B.
A.I. Advisor
published General Information

General Information

a developer of patient-specific expanded cellular therapies for use in the treatment of patients with diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
64 Sidney Street
Phone
+1 617 588-5555
Employees
314
Web
https://www.vcel.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ARRFX14.180.24
+1.72%
AMG River Road Focused Absolute Value N
SGOIX29.740.17
+0.57%
First Eagle Overseas I
OEQIX8.970.02
+0.22%
Oaktree Emerging Markets Equity I
WCMGX31.37N/A
N/A
First Trust WCM Focused Global Gr Inst
SDGAX129.30-0.59
-0.45%
DWS Capital Growth A

VCEL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VCEL has been loosely correlated with RXRX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if VCEL jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VCEL
1D Price
Change %
VCEL100%
+7.11%
RXRX - VCEL
37%
Loosely correlated
+2.19%
BEAM - VCEL
37%
Loosely correlated
+2.43%
MNMD - VCEL
37%
Loosely correlated
-3.12%
DNA - VCEL
36%
Loosely correlated
+17.93%
SYRE - VCEL
35%
Loosely correlated
+0.86%
More